COVID-19 vaccines
COVID-19 vaccines has been studied in 4 papers since 2021: 1 observational study in people, 3 reviews; 1 in the past year. The newest paper, Aug 3, 2026: “Recent research on vaccines for older adults”.
1 new paper in 30 daysSee all 4
“Two vaccine doses achieved high responses across all ages.”
- 1 lab in 1 country
- Funders: Department of Health and Social Care and others
- 1 of 1 finding with company ties
- Humans1
What did studies of COVID-19 vaccines find?
3Studies of COVID-19 vaccines measured 3 outcomes; the most studied are mortality (1 study), infection (1) and SARS-CoV-2 antibodies (1).
Mortality
downin humans1
1 study
Mortality
downin humans1
COVID-19 vaccines decrease mortality in humans.
“Studies involving care-home residents demonstrated that COVID-19 vaccines provided substantial protection against infection and, particularly, mortality”
Reviewcare-home residents
Recent research on vaccines for older adults
Age and ageing
Infection
downin humans1
1 study
Infection
downin humans1
COVID-19 vaccines protect against infection in humans.
“Studies involving care-home residents demonstrated that COVID-19 vaccines provided substantial protection against infection and, particularly, mortality”
Reviewcare-home residents
Recent research on vaccines for older adults
Age and ageing
SARS-CoV-2 antibodies
upin humans1
1 study
SARS-CoV-2 antibodies
upin humans1
COVID-19 vaccines increase SARS-CoV-2 antibodies in humans.
“Two vaccine doses achieved high responses across all ages.”
Humansacross all agestwo vaccine doses
Nature microbiology